Handheld device holds promise for onsite cancer diagnosis

09/7/2011 | PBS

Researchers at Michigan State University and the University of Michigan have created a handheld device called Gene-Z that they say could aid in cancer diagnosis in underserved areas. The device, which features a microfluidic chip, allows providers to analyze blood samples onsite and transmits the readings to an Android tablet, iPad or iPod Touch.

View Full Article in:

PBS

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN